Navigation Links
ACC Concerned Over Reporting of Biomonitoring Results
Date:10/23/2007

inform us about how the chemical was introduced, how long it has been there, or whether it poses any health risk what so ever. It would be erroneous to suggest that just because effects can be observed in toxicity studies at high doses of a chemical, that the same effects would occur at much, much lower doses.

The chemical industry recognizes that environmental health issues represent a legitimate concern, and we both recognize and act on our responsibility to help preserve a healthy environment, not only for our own children, but also for future generations. This is a fundamental responsibility we take seriously. ACC members meet this responsibility through compliance with a network of regulatory safeguards including many federal and state laws and through voluntary programs, such as Responsible Care(R), the HPV Challenge and the Voluntary Children's Chemical Evaluation Program Pilot. (VCCEP). Annually, our industry invests over $26 billion on research and innovation, $14 billion on complying with the dozens of federal, and hundreds of state regulations that govern the products, processes and distribution of the products of chemistry, and above that ACC members have invested over $120 million over the past five years in research to evaluate health and environmental impacts of chemicals -- much of which relates to the interpretation of biomonitoring data.

To Learn More About Biomonitoring and Responsible Reporting of Results:

Centers for Disease Control and Prevention

http://www.cdc.gov/exposurereport/

National Academy of Sciences

http://www.nap.edu/catalog.php?record_id=11700

BiomonitoringInfo.Org http://www.biomonitoringinfo.org

http://www.americanchemistr
'/>"/>

SOURCE American Chemistry Council
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)...   DigiPath Labs , the cannabis testing subsidiary ... True North Laboratory of Ann Arbor, Michigan ... global supplier of diagnostic solutions for food-borne pathogens, to ... rapid diagnostic test kits to screen for food-borne pathogens ... joint effort is expected to result in the first ...
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma Corp. ... to report its second quarter 2015 financial results on ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... the event can be obtained as follows: ...
(Date:7/27/2015)... , July 28, 2015   Regeneron Pharmaceuticals, ... a new global collaboration to discover, develop and commercialize ... immuno-oncology. As part of the agreement, the two companies ... (PD-1) inhibitor currently in Phase 1 testing and plan ... candidates based on ongoing, innovative preclinical programs. ...
Breaking Medicine Technology:DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8
... WILMINGTON, N.C., Oct. 23 PPD, Inc. ... Sydney, Australia;,Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru; ... key therapeutic areas. The four new offices ... in response to increasing client demand. With,an office ...
... Blueprint for Future, WASHINGTON, Oct. 23 ... latest report from the,Association of Academic Health Centers ... trials in the U.S. and a blueprint for ... academic health,centers nationwide. The infrastructure for clinical trials ...
Cached Medicine Technology:PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal 2AAHC Examines Nation's Clinical Trials Infrastructure 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... has authorized the Company, from time to time and depending on market conditions, ... up to $25 million. Repurchases will be made in open market or privately ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... more common in shipbreaking workers than they are in the general population. Surviving ... to read it now. , Researchers at Taiwan’s National Health Research Institutes ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... a proprietary, web based clinical knowledge system, called “Referral Guidance.” , ... It provides physicians who are anticipating making a subspecialty referral an efficient means ...
(Date:7/28/2015)... ... , ... Women fear developing Alzheimer's disease more than having a heart attack ... are treatable, but there is little an individual can do to arrest the progress ... clinical trial, reports the July 2015 Harvard Women's Health Watch . , "There ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa ... Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty ... esteemed colleagues and peers in the metro area as one of the most respected ...
Breaking Medicine News(10 mins):Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... Cancer is a common condition in India where beetle and ... found that certain bacteria’s excessive presence may give an early ... report published in the Open Access journal, Journal of Translational ... called squamous cell carcinoma) have six common species of ...
... affects young women and the condition// can sometimes be fatal. ... in the basal ganglia region of the brain. ,People ... and are unaware of the seriousness of their condition.When you ... the famous talented singer Karen Carpenter who died in the ...
... Oxidized phospholipids can be tested in blood to indicate the ... ,A report in the 7th July issue of New England ... phospholipids may indicate the amount of fatty build- up ... future be able to avoid the use of invasive ...
... British Columbia had showed that noise// might be not a ... so when that is effectively used to help the older ... the one sensation that comes in our way of concentration ... related to the disturbances that cause distractions in hearing something. ...
... role of fats, had been debated for a long// time. ... the between the various kinds of fats that are heart ... by banishing one kind of fat totally and taking only ... can help achieve the best possible diet for reducing cholesterol ...
... In a major breakthrough in the advancement of ... scan rare genetic mutation at a fraction of ... array diagonal gel electrophoresis. ,The technology devised ... in collaboration with Bristol, University college London, British ...
Cached Medicine News:Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
Sleek, all-metal head with large-diameter viewing window. 3X magnification....
Provides 30% more magnification and twice the field of view. Adjustable focus....
... FSE are a new series of cryostats ... outside of the cryochamber, which allows easy ... temperature adjustment. Simple, multi-lingual touch-screen display for ... the main touch-screen display. Angle of clamp ...
... Spectra photocoagulator delivers power and reliability ... (DPSS) technology. Diode side-pumping technology drives ... compact Novus Spectra system, and active ... output and system reliability from your ...
Medicine Products: